The Women's Health Edition
The Female Hormone Playbook
Understand your own rhythm. Prepare for your next chapter.
Begin reading
Your hormone story is allowed to change
Hormonal patterns change across the reproductive years, perimenopause and menopause, and symptoms deserve to be understood in that context (European Society of Endocrinology: menopause guideline (2025)). A useful playbook connects the pattern you notice with appropriate evaluation and treatment, rather than treating every change as a failure to “balance” yourself.
This guide follows six major signals, the cycle, life stages, testing questions and practical care options. It is designed to help you prepare for a conversation, not diagnose yourself from a chart.
Six signals worth understanding
The reproductive system uses coordinated feedback among the brain, pituitary and ovaries, rather than one hormone acting alone (How to study the menstrual cycle: methods and recommendations (2020/2021)). The meaning of a result depends on reproductive stage, medications, timing and the clinical question.
| Signal | What it helps explain |
|---|---|
| Estradiol | A major estrogen involved in reproductive physiology; changing levels matter across the cycle and menopausal transition (How to study the menstrual cycle: methods and recommendations (2020/2021); European Society of Endocrinology: menopause guideline (2025)). |
| Progesterone | Its rise after ovulation helps distinguish the luteal phase from the earlier follicular phase (How to study the menstrual cycle: methods and recommendations (2020/2021)). |
| FSH | A pituitary signal involved in follicle development; whether testing helps depends on age and the diagnostic setting (European Society of Endocrinology: menopause guideline (2025)). |
| LH | Its surge is part of the ovulatory process, although calendar prediction alone cannot establish that ovulation occurred (How to study the menstrual cycle: methods and recommendations (2020/2021)). |
| Testosterone | It has physiological roles in women; the best-established therapeutic indication is carefully assessed HSDD in selected postmenopausal women, not a general energy or anti-aging target (Global consensus on testosterone therapy for women (2019)). |
| Prolactin | It belongs in selected diagnostic workups, not automatically in every wellness panel; clinical context guides additional endocrine evaluation (European Society of Endocrinology: menopause guideline (2025)). |
Thyroid function is also relevant when symptoms suggest a thyroid disorder, but a thyroid test is not a universal explanation for every cycle or menopausal symptom (American Thyroid Association: Thyroid function tests).
The cycle is a pattern, not a 28-day rule
Cycle length and symptoms vary, and a menstrual bleed does not prove ovulation occurred (How to study the menstrual cycle: methods and recommendations (2020/2021); Australian Sports Commission: menstrual cycle and sport). A 28-day diagram can teach the sequence, but should not be used to tell someone that ovulation must occur on day 14.
Bleeding and the early follicular phase
Menstrual bleeding marks the beginning of a new cycle, and it overlaps with the follicular phase rather than being a completely separate hormonal system (Cleveland Clinic: menstrual-cycle phases; How to study the menstrual cycle: methods and recommendations (2020/2021)). Track timing, flow, pain and functional impact if those details will help your clinician.
The later follicular phase
Follicular development and changing estradiol are part of the approach to ovulation, but the length of this phase varies substantially (How to study the menstrual cycle: methods and recommendations (2020/2021)). That variability is one reason an app's forecast should not be treated as a laboratory measurement.
Ovulation
The ovulatory process includes an LH surge, but symptoms and calendar estimates alone do not reliably establish the exact day for every person (How to study the menstrual cycle: methods and recommendations (2020/2021)). Hormonal contraception, pregnancy, breastfeeding and some medical conditions change how a standard cycle diagram applies.
The luteal phase
Progesterone rises after ovulation, and some people notice meaningful symptoms as ovarian hormones change (How to study the menstrual cycle: methods and recommendations (2020/2021)). Not everyone experiences premenstrual deterioration, and prospective symptom tracking is more informative than assuming an entire week must feel a certain way.
Three life stages, different questions
Reproductive stage changes how clinicians interpret bleeding, symptoms and laboratory results (European Society of Endocrinology: menopause guideline (2025)). The right question is not “What is the perfect hormone number?” but “What explanation and care plan fit this stage of my life?”
- Reproductive years: Discuss pain, heavy bleeding, missed periods, pregnancy possibility, contraception and symptoms that affect daily life; severe or unusual patterns deserve assessment (Cleveland Clinic: menstrual-cycle phases).
- Perimenopause: Changing cycles and symptoms can occur while ovarian function fluctuates, so an isolated hormone measurement may not capture the whole picture (European Society of Endocrinology: menopause guideline (2025)).
- Menopause and beyond: Treatment decisions can address bothersome symptoms, genitourinary concerns and bone health while considering individual risks and timing (European Society of Endocrinology: menopause guideline (2025); The Menopause Society: Hormone therapy position statement (2022)).
Possible early menopause or premature ovarian insufficiency requires a specific evaluation rather than an assumption that all symptoms are ordinary aging (European Society of Endocrinology: menopause guideline (2025)). Bleeding after menopause also needs assessment instead of being attributed casually to “hormone shifts.”
Testing should answer a question
For many otherwise healthy people over 45 with typical menopausal symptoms, diagnosis is primarily clinical; routine broad hormone testing is often unnecessary (European Society of Endocrinology: menopause guideline (2025)). Testing becomes more useful when age, symptoms, reproductive history or other features raise a different question.
| Question to bring | How testing may help |
|---|---|
| Could pregnancy or another condition explain the change? | History and targeted tests can distinguish competing explanations (European Society of Endocrinology: menopause guideline (2025)). |
| Is thyroid dysfunction plausible? | TSH and related testing are interpreted as a pattern, not a single “optimal” target (American Thyroid Association: Thyroid function tests). |
| Is early ovarian insufficiency a concern? | Age-specific evaluation and appropriately interpreted hormone testing may be needed (European Society of Endocrinology: menopause guideline (2025)). |
| Are low-desire symptoms causing distress? | Assessment includes medical, medication, relationship and psychological context; a testosterone level alone does not diagnose HSDD (ISSWSH: Testosterone for HSDD in women (2021)). |
| Are symptoms reliably linked to the cycle? | Daily prospective records across cycles can be more useful than retrospective impressions, especially for suspected PMDD (How to study the menstrual cycle: methods and recommendations (2020/2021)). |
Ask what will change based on each result. More tests are not automatically more personalized care.
The modern hormone-therapy conversation
Menopausal hormone therapy can be effective for bothersome vasomotor symptoms and can help prevent bone loss in appropriate patients (The Menopause Society: Hormone therapy position statement (2022); European Society of Endocrinology: menopause guideline (2025)). Decisions depend on age, time since menopause, symptoms, uterus status, history and the specific formulation.
Systemic estrogen generally requires appropriate endometrial protection when a uterus is present; the exact regimen is individualized (The Menopause Society: Hormone therapy position statement (2022)). Local treatment for genitourinary symptoms and systemic treatment for broader symptoms are not interchangeable decisions.
The WHI findings should neither be dismissed nor applied as one identical risk estimate to every current patient and formulation (European Society of Endocrinology: menopause guideline (2025)). Regimen, route, duration and baseline risk matter, and observational comparisons between routes do not replace randomized head-to-head evidence.
Hormone therapy is not prescribed simply to prevent cardiovascular disease or dementia, and certain histories can make systemic treatment inappropriate (European Society of Endocrinology: menopause guideline (2025)). Discuss unexplained bleeding, breast cancer history, clotting or stroke history, liver disease and other relevant risks before treatment.
U.S. hormone-product labeling has changed, so clinical review should use the current label for the exact product rather than an old screenshot or blanket statement about all hormones (FDA: Approved menopausal hormone therapy label changes (February 2026)). Nothing in a blog grants individual eligibility.
Testosterone: a precise discussion
The international consensus identifies HSDD in appropriately assessed postmenopausal women as the evidence-based indication for testosterone therapy, with product and monitoring considerations (Global consensus on testosterone therapy for women (2019)). It does not establish testosterone as a universal treatment for fatigue, muscle gain, cognition or general wellbeing.
Guidance emphasizes a biopsychosocial assessment and monitoring that avoids supraphysiologic exposure (ISSWSH: Testosterone for HSDD in women (2021)). A laboratory value can inform safe use but is not, by itself, a diagnosis of low sexual desire.
Five practical levers
Lifestyle can support health and function without requiring a promise to normalize every hormone (American Heart Association: Life's Essential 8; Australian Sports Commission: menstrual cycle and sport). These levers work best as adaptable habits, not rules about what a woman must do in each cycle phase.
- Sleep: Address persistent insomnia, hot flashes or suspected sleep apnea rather than accepting disrupted nights indefinitely (European Society of Endocrinology: menopause guideline (2025); NINDS: Brain Basics, Understanding Sleep).
- Nourishment: Use a broadly nutritious pattern and avoid under-fueling in pursuit of a smaller body or a stricter routine (American Heart Association: dietary guidance (2021); Australian Sports Commission: menstrual cycle and sport).
- Movement: Match training to symptoms and recovery; current evidence does not justify a universal phase-based strength-training prescription (Australian Sports Commission: menstrual cycle and sport).
- Symptom awareness: Track the patterns that affect you, not those an app says you should feel (How to study the menstrual cycle: methods and recommendations (2020/2021)).
- Exposure and supplement awareness: Review products and medicines rather than assuming “natural” means suitable; endocrine-disruptor education and targeted treatment questions are separate from a generic detox plan (NIEHS: Endocrine disruptors; NCCIH: Ashwagandha, usefulness and safety).
When to seek help sooner
Severe pain, unusually heavy or prolonged bleeding, bleeding between periods, absent periods without explanation or possible pregnancy should prompt a care conversation (Cleveland Clinic: menstrual-cycle phases). Sudden severe symptoms, fainting or symptoms suggesting an emergency require urgent assessment, not routine tracking.
If symptoms are disrupting work, relationships, exercise or sleep, that impact is enough reason to ask for help. You do not have to wait until every laboratory number looks abnormal.
A more useful definition of balance
Balance does not mean a flat hormone graph. It means understanding normal variation, recognizing a problem when it matters, and choosing a plan whose benefits and risks fit your goals (How to study the menstrual cycle: methods and recommendations (2020/2021); European Society of Endocrinology: menopause guideline (2025)).
Your next step
Bring your questions, medication list, and relevant results to a conversation with licensed medical providers. Infinity Functional Performance can help you explore whether an individualized evaluation is appropriate; no particular test, medication, or result is promised.
Visit ifp.life, call 972-619-5350, or email info@ifp.life to learn about becoming a patient.
Educational content only. This article is not a diagnosis, prescription, or substitute for individual medical advice. Do not start, stop, or adjust treatment based on a blog.
Numbered references
- NINDS: Brain Basics, Understanding Sleep
- American Heart Association: Life's Essential 8
- American Heart Association: dietary guidance (2021)
- European Society of Endocrinology: menopause guideline (2025)
- Cleveland Clinic: menstrual-cycle phases
- How to study the menstrual cycle: methods and recommendations (2020/2021)
- Australian Sports Commission: menstrual cycle and sport
- The Menopause Society: Hormone therapy position statement (2022)
- FDA: Approved menopausal hormone therapy label changes (February 2026)
- Global consensus on testosterone therapy for women (2019)
- ISSWSH: Testosterone for HSDD in women (2021)
- NIEHS: Endocrine disruptors
- NCCIH: Ashwagandha, usefulness and safety
- American Thyroid Association: Thyroid function tests